Skip to main content

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Tarsus Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
0 vs. Q2 2021
Shares held
12.9M
−192.2K (−1.5%) vs. Q2 2021
Total value
$277.4M
−$101.2M (−26.7%) vs. Q2 2021
New holders
6
10 more added
Sold out
6
16 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 44 institutions
Q1 2021: 41 institutionsQ2 2021: 44 institutionsQ3 2021: 44 institutionsQ4 2021: 43 institutionsQ1 2022: 51 institutionsQ2 2022: 73 institutionsQ3 2022: 75 institutionsQ4 2022: 69 institutionsQ1 2023: 74 institutionsQ2 2023: 92 institutionsQ3 2023: 105 institutionsQ4 2023: 116 institutionsQ1 2024: 157 institutionsQ2 2024: 148 institutionsQ3 2024: 162 institutionsQ4 2024: 195 institutionsQ1 2025: 195 institutionsQ2 2025: 205 institutionsQ3 2025: 220 institutionsQ4 2025: 246 institutionsQ1 2026: 253 institutionsQ2 2026: 256 institutions
Value heldQ3 2021: $277.4M
Q1 2021: $410.4MQ2 2021: $378.5MQ3 2021: $277.4MQ4 2021: $294.2MQ1 2022: $222.2MQ2 2022: $291.7MQ3 2022: $350.8MQ4 2022: $301.0MQ1 2023: $252.1MQ2 2023: $387.3MQ3 2023: $529.4MQ4 2023: $652.0MQ1 2024: $1.43BQ2 2024: $1.09BQ3 2024: $1.43BQ4 2024: $2.23BQ1 2025: $2.26BQ2 2025: $1.87BQ3 2025: $2.67BQ4 2025: $3.61BQ1 2026: $3.17BQ2 2026: $2.98B
Institutions holding TARS and their total value by quarter
QuarterHoldersValue
Q2 2026256$2.98B
Q1 2026253$3.17B
Q4 2025246$3.61B
Q3 2025220$2.67B
Q2 2025205$1.87B
Q1 2025195$2.26B
Q4 2024195$2.23B
Q3 2024162$1.43B
Q2 2024148$1.09B
Q1 2024157$1.43B
Q4 2023116$652.0M
Q3 2023105$529.4M
Q2 202392$387.3M
Q1 202374$252.1M
Q4 202269$301.0M
Q3 202275$350.8M
Q2 202273$291.7M
Q1 202251$222.2M
Q4 202143$294.2M
Q3 202144$277.4M
Q2 202144$378.5M
Q1 202141$410.4M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q2 2021.

Institutions holding TARS in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vivo Capital, LLC2,987,331$64.4M2.89%00.0%Unchanged
RTW Investments, LP2,013,601$43.4M0.65%00.0%Unchanged
Cormorant Asset Management, LP1,444,831$31.1M1.27%−69,438−4.6%Reduced
Frazier Management LLC1,417,157$30.5M2.44%00.0%Unchanged
Perceptive Advisors LLC1,296,416$27.9M0.41%00.0%Unchanged
TimesSquare Capital Management, LLC650,780$14.0M0.12%−35,925−5.2%Reduced
Cowen and Company, LLC514,289$11.1M0.53%00.0%Unchanged
BlackRock Inc.441,620$9.52M0.00%+3,264+0.7%Added
Vanguard Group Inc428,990$9.24M0.00%+2,945+0.7%Added
Jefferies Group LLC422,993$9.12M0.22%−20,000−4.5%Reduced
Sands Capital Ventures, LLC260,000$5.60M0.84%+260,000New
Ensign Peak Advisors, Inc200,000$4.31M0.01%00.0%Unchanged
Ghost Tree Capital, LLC170,000$3.66M1.21%00.0%Unchanged
State Street Corp126,802$2.73M0.00%+7,661+6.4%Added
Geode Capital Management, LLC123,698$2.67M0.00%−1,823−1.5%Reduced
Northern Trust Corp74,011$1.59M0.00%−5,624−7.1%Reduced
Charles Schwab Investment Management Inc46,766$1.01M0.00%+193+0.4%Added
SG Americas Securities, LLC46,253$997.0K0.01%+23,276+101.3%Added
Invesco Ltd.28,614$616.0K0.00%−1,814−6.0%Reduced
Morgan Stanley28,530$615.0K0.00%+20,248+244.5%Added
Goldman Sachs Group Inc26,480$571.0K0.00%−400−1.5%Reduced
Bank of New York Mellon Corp24,523$529.0K0.00%+2,950+13.7%Added
Nuveen Asset Management, LLC21,763$496.0K0.00%−3,960−15.4%Reduced
J. Goldman & Co LP22,198$478.0K0.04%−11,553−34.2%Reduced
Wells Fargo & Company9,784$210.0K0.00%+9,784New
Virtus ETF Advisers LLC6,008$129.0K0.06%−311−4.9%Reduced
New York State Common Retirement Fund5,881$127.0K0.00%−3,472−37.1%Reduced
Bank of America Corp5,771$125.0K0.00%+3,811+194.4%Added
Deutsche Bank AG5,417$116.0K0.00%−157−2.8%Reduced
American International Group, Inc.4,614$99.0K0.00%−110−2.3%Reduced
California State Teachers Retirement System4,520$97.0K0.00%−7,124−61.2%Reduced
JPMorgan Chase & Co3,237$70.0K0.00%−1,925−37.3%Reduced
STRS Ohio2,100$45.0K0.00%00.0%Unchanged
Citigroup Inc962$21.0K0.00%+561+139.9%Added
Royal Bank of Canada925$20.0K0.00%+348+60.3%Added
Legal & General Group Plc818$18.0K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.515$11.0K0.00%00.0%Unchanged
UBS Group AG500$11.0K0.00%+500New
Tower Research Capital LLC (TRC)465$10.0K0.00%−708−60.4%Reduced
Advisor Group Holdings, Inc.200$4.00K0.00%+200New
Spire Wealth Management100$2.00K0.00%00.0%Unchanged
Parallel Advisors, LLC44$1.00K0.00%+44New
American Portfolios Advisors39$8400.00%+39New
Tucker Asset Management LLC4$1110.00%00.0%Unchanged
Sands Capital Management, LLC0$00.00%−260,000−100.0%Sold out
Altium Capital Management LP0$00.00%−70,573−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−16,686−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−8,600−100.0%Sold out
Hunter Perkins Capital Management, LLC0$00.00%−7,780−100.0%Sold out
Signaturefd, LLC0$00.00%−27−100.0%Sold out